Refractive errors in Cameroonians diagnosed with complete oculocutaneous albinism
Received 16 September 2012
Accepted for publication 8 April 2013
Published 22 July 2013 Volume 2013:7 Pages 1491—1495
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
André Omgbwa Eballé1,3, Côme Ebana Mvogo2, Christelle Noche4, Marie Evodie Akono Zoua2, Andin Viola Dohvoma2
1Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon, 2Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon; 3Yaoundé Gynaeco-obstetric and Paediatric Hospital. Yaoundé, Cameroon; 4Faculty of Medicine, Université des Montagnes. Bangangté, Cameroon
Background: Albinism causes significant eye morbidity and amblyopia in children. The aim of this study was to determine the refractive state in patients with complete oculocutaneous albinism who were treated at the Gynaeco-Obstetric and Paediatric Hospital, Yaoundé, Cameroon and evaluate its effect on vision.
Methods: We carried out this retrospective study at the ophthalmology unit of our hospital. All oculocutaneous albino patients who were treated between March 1, 2003 and December 31, 2011 were included.
Results: Thirty-five patients (70 eyes) diagnosed with complete oculocutaneous albinism were enrolled. Myopic astigmatism was the most common refractive error (40%). Compared with myopic patients, those with myopic astigmatism and hypermetropic astigmatism were four and ten times less likely, respectively, to demonstrate significant improvement in distance visual acuity following optical correction.
Conclusion: Managing refractive errors is an important way to reduce eye morbidity-associated low vision in oculocutaneous albino patients.
Keywords: albinism, visual acuity, refraction, Cameroon
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]